Bank of Nova Scotia
NVAX icon

Bank of Nova Scotia’s Novavax NVAX Stock Holding History

Bank of Nova Scotia’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-47,783
Closed -$6.89M – 1271
2021
Q4 		$6.89M Sell
47,783
-20,117
-30% -$3.46M 0.01% 633
2021
Q3 		$14.1M Buy
67,900
+46,588
+219% +$10.3M 0.02% 412
2021
Q2 		$4.52M Buy
21,312
+19,414
+1,023% +$3.56M 0.01% 616
2021
Q1 		$344K Sell
1,898
-3,886
-67% -$774K ﹤0.01% 1000
2020
Q4 		$645K Buy
+5,784
New +$615K ﹤0.01% 832

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Nova Scotia's NVAX Position: Q1 2022 in Review

Bank of Nova Scotia sold out of Novavax (NVAX) in Q1 2022, closing a stake of 47,783 shares — an estimated $6.89M sold.

Bank of Nova Scotia first reported a position in NVAX in Q4 2020 and held it in 5 quarters. The position peaked at $14.1M in Q3 2021. 382 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Bank of Nova Scotia reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Bank of Nova Scotia sold 47,783 Novavax shares in Q1 2022, an estimated $6.89M.
  • Bank of Nova Scotia first reported a position in Novavax in Q4 2020 and held it in 5 quarters.
  • Bank of Nova Scotia's Novavax position peaked at $14.1M in Q3 2021.
  • 382 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Bank of Nova Scotia's 13F filing for Q1 2022, filed 9 May 2022.